MIRA Pharmaceuticals, Inc. (MIRA)

USD 1.05

(-1.87%)

Long Term Debt Summary of MIRA Pharmaceuticals, Inc.

MIRA Pharmaceuticals, Inc.'s latest annual long term debt in 2023 was - USD , down -100.0% from previous year.
MIRA Pharmaceuticals, Inc.'s latest quarterly long term debt in 2024 Q2 was - USD , down 0.0% from previous quarter.
MIRA Pharmaceuticals, Inc. reported annual long term debt of 84.26 Thousand USD in 2022, down 0.0% from previous year.
MIRA Pharmaceuticals, Inc. reported annual long term debt of - USD in 2021, down 0.0% from previous year.
MIRA Pharmaceuticals, Inc. reported quarterly long term debt of - USD for 2024 Q2, down 0.0% from previous quarter.
MIRA Pharmaceuticals, Inc. reported quarterly long term debt of - USD for 2023 FY, down -100.0% from previous quarter.

Annual Long Term Debt Chart of MIRA Pharmaceuticals, Inc. (2023 - 2020)

Historical Annual Long Term Debt of MIRA Pharmaceuticals, Inc. (2023 - 2020)

Year	Long Term Debt	Long Term Debt Growth
2023	- USD	-100.0%
2022	84.26 Thousand USD	0.0%
2021	- USD	0.0%
2020	- USD	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q1	- USD	0.0%
2024 Q2	- USD	0.0%
2023 FY	- USD	-100.0%
2023 Q2	51.47 Thousand USD	-24.53%
2023 Q1	68.2 Thousand USD	-19.06%
2023 Q4	- USD	-100.0%
2023 Q3	34.52 Thousand USD	-32.92%
2022 Q4	84.26 Thousand USD	0.0%
2022 FY	84.26 Thousand USD	0.0%
2022 Q3	- USD	0.0%
2022 Q1	136.22 Thousand USD	0.0%
2021 Q1	- USD	0.0%
2021 FY	- USD	0.0%
2020 FY	- USD	0.0%

Peer Long Term Debt Comparison of MIRA Pharmaceuticals, Inc.

Name	Long Term Debt	Long Term Debt Difference
Amgen Inc.	63.17 Billion USD	100.0%
AstraZeneca PLC	23.22 Billion USD	100.0%
Biogen Inc.	7.18 Billion USD	100.0%
Gilead Sciences, Inc.	23.18 Billion USD	100.0%
Scilex Holding Company	17.03 Million USD	100.0%
Scilex Holding Company	17.03 Million USD	100.0%